Bleeding-stopping pain-relieving paste

Abstract

The invention discloses bleeding-stopping pain-relieving paste which is prepared by mixing pain-relieving drug powder with medicinal paste, wherein the pain-relieving drug powder is prepared from the following raw materials in percentage by weight: 30%-60% of traditional Chinese medicinal materials A, 10%-40% of traditional Chinese medicinal materials B and 10%-30% of traditional Chinese medicinal materials C; the traditional Chinese medicinal materials A are damnacanthus indicus, costustoot, radix aconiti agrestis, hosta plantaginea, myrrh, common wedgelet fern herb, musk, pangolin, cinnamon, radix angelicae pubescentis, cortex phellodendri, eupolyphoge sinensis, radix clematidis, clerodendrum bungei and radix ampelopsis; the traditional Chinese medicinal materials B are one or more of monkshood, fatsia japonica and acutangular anisodus root; the traditional Chinese medical materials C are artemisia anomala. According to the bleeding-stopping pain-relieving paste disclosed by the invention, various Chinese herbal medicines are mutually combined with each other to effectively and quickly treat diseases such as rheumatoid, gout, cervical spondylosis, lumbar disc herniation, numbness of limbs and the like. Moreover, the preparation method is simple and the bleeding-stopping pain-relieving paste is obvious in bleeding-stopping effect.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a hemostatic and analgesic ointment for treating rheumatoid, ventilation, cervical spondylosis, lumbar disc herniation and limb swelling. Background technique [0002] Existing medicines for the treatment of diseases such as rheumatoid, ventilation, cervical spondylosis, lumbar intervertebral disc herniation, swelling of extremities and other diseases in the market have large side effects and low curative effect. Some analgesic and anti-inflammatory creams that are more commonly used in clinical use often cause skin itching in patients, and the therapeutic effect is not satisfactory due to poor drug penetration. [0003] The Chinese invention patent application with the application number 200810138303.4 discloses a bone hyperplasia relieving pain ointment, which is made of the following raw materials in parts by weight: musk 0.8-1.5; lovage 20-40; notopterygium 25-35;...

AI Technical Summary

Problems solved by technology

Although the hemostatic and analgesic ointment has a simple preparation method, its treatment of hyperosteogeny, intervertebral disc herniation, ankylosing spondylitis, calcaneal spurs, and rheumatism and rheumatoid arthritis has a long curative course